BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29428877)

  • 21. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
    Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
    Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.
    Korecka JA; van Kesteren RE; Blaas E; Spitzer SO; Kamstra JH; Smit AB; Swaab DF; Verhaagen J; Bossers K
    PLoS One; 2013; 8(5):e63862. PubMed ID: 23724009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
    Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
    Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
    Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
    Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
    Jantas D; Roman A; Kuśmierczyk J; Lorenc-Koci E; Konieczny J; Lenda T; Lasoń W
    Neurotox Res; 2013 Jul; 24(1):41-54. PubMed ID: 23307753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson's disease.
    Kusuda Y; Takemura A; Nakano M; Ishihara A
    Neurosci Res; 2018 Jul; 132():58-62. PubMed ID: 29196223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
    Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
    Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of endoplasmic reticulum stress in Parkinson's disease.
    Tsujii S; Ishisaka M; Hara H
    Eur J Pharmacol; 2015 Oct; 765():154-6. PubMed ID: 26297973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.